Medical and Pharmaceutical QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics LEX Diagnostics develops molecular diagnostics to improve patient care by delivering clinical insights Joseph MortonJune 6, 2025
Medical and Pharmaceutical Dying woman blames CT scan technicians for cancer spread, files lawsuit Their failure to properly interpret the results will cost her life, she claims Rowan DunneJune 6, 2025
Medical and Pharmaceutical The NHS in England introduces innovative new cancer detection options The test will detect a wider range of genetic variants to determine eligibility for targeted treatment Joseph MortonJune 5, 2025
Medical and Pharmaceutical Combining mammograms with lung cancer screening can boost female uptake A recent study from Stanford Medicine made this conclusion Rowan DunneJune 4, 2025
Medical and Pharmaceutical Australia’s first national lung cancer screening program begins in July The aim of the game is to save 12,000 lives by 2035 Rowan DunneJune 3, 2025
Medical and Pharmaceutical DNA blood biopsy to identify personalized treatments for lung cancer patients Thousands in the UK will soon benefit from the state-of-the-art test developed by Guardant Health Rowan DunneMay 30, 2025
Medical and Pharmaceutical Against the rise of early onset cancer: a Mugglehead roundup Cancer treatment markets are set to expand rapidly over the next decade Joseph MortonMay 29, 2025
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph MortonMay 27, 2025
Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph MortonMay 26, 2025
Medical and Pharmaceutical Prenetics Global shares spike on significant revenue developments The company projects 2025 revenue to range between USD$73 million and USD$85 million Joseph MortonMay 22, 2025